Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Med Chem
1998 Jun 18;4113:2201-6. doi: 10.1021/jm980183o.
Show Gene links
Show Anatomy links
A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
Jacobson KA
,
Kim YC
,
Wildman SS
,
Mohanram A
,
Harden TK
,
Boyer JL
,
King BF
,
Burnstock G
.
???displayArticle.abstract???
Analogues of the P2 receptor antagonists pyridoxal-5'-phosphate and the 6-azophenyl-2',4'-disulfonate derivative (PPADS), in which the phosphate group was cyclized by esterification to a CH2OH group at the 4-position, were synthesized. The cyclic pyridoxine-alpha4, 5-monophosphate, compound 2 (MRS 2219), was found to be a selective potentiator of ATP-evoked responses at rat P2X1 receptors with an EC50 value of 5.9 +/- 1.8 microM, while the corresponding 6-azophenyl-2',5'-disulfonate derivative, compound 3 (MRS 2220), was a selective antagonist. The potency of compound 3 at the recombinant P2X1 receptor (IC50 10.2 +/- 2.6 microM) was lower than PPADS (IC50 98.5 +/- 5.5 nM) or iso-PPADS (IC50 42.5 +/- 17.5 nM), although unlike PPADS its effect was reversible with washout and surmountable. Compound 3 showed weak antagonistic activity at the rat P2X3 receptor (IC50 58.3 +/- 0.1 microM), while at recombinant rat P2X2 and P2X4 receptors no enhancing or antagonistic properties were evident. Compounds 2 and 3 were found to be inactive as either agonists or antagonists at the phospholipase C-coupled P2Y1 receptor of turkey erythrocytes, at recombinant human P2Y2 and P2Y4 receptors, and at recombinant rat P2Y6 receptors. Similarly, compounds 2 and 3 did not have measurable affinity at adenosine A1, A2A, or A3 receptors. The lack of an aldehyde group in these derivatives indicates that Schiff's base formation with the P2X1 receptor is not necessarily required for recognition of pyridoxal phosphate derivatives. Thus, compounds 2 and 3 are relatively selective pharmacological probes of P2X1 receptors, filling a long-standing need in the P2 receptor field, and are also important lead compounds for future studies.
???displayArticle.pubmedLink???
9632352
???displayArticle.pmcLink???PMC10791483 ???displayArticle.link???J Med Chem ???displayArticle.grants???[+]
Abbracchio,
Purinoceptors: are there families of P2X and P2Y purinoceptors?
1994, Pubmed
Abbracchio,
Purinoceptors: are there families of P2X and P2Y purinoceptors?
1994,
Pubmed
Barajas-López,
P2x-purinoceptors of myenteric neurones from the guinea-pig ileum and their unusual pharmacological properties.
1996,
Pubmed
Boyer,
Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
1994,
Pubmed
Boyer,
Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides.
1989,
Pubmed
Brake,
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
1994,
Pubmed
,
Xenbase
Buell,
An antagonist-insensitive P2X receptor expressed in epithelia and brain.
1996,
Pubmed
Buell,
P2X receptors: an emerging channel family.
1996,
Pubmed
Burnstock,
Purinergic receptors: their role in nociception and primary afferent neurotransmission.
1996,
Pubmed
Burnstock,
P2 purinoceptors: historical perspective and classification.
1996,
Pubmed
Camaioni,
Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.
1998,
Pubmed
Chen,
Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages.
1996,
Pubmed
Collo,
Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.
1996,
Pubmed
Communi,
Receptors responsive to extracellular pyrimidine nucleotides.
1997,
Pubmed
Daniel,
Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets.
1998,
Pubmed
Evans,
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
1995,
Pubmed
Fredholm,
Towards a revised nomenclature for P1 and P2 receptors.
1997,
Pubmed
Gu,
Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses.
1997,
Pubmed
Harden,
Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes.
1988,
Pubmed
King,
Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor.
1997,
Pubmed
,
Xenbase
King,
P2 purinoceptor-activated inward currents in follicular oocytes of Xenopus laevis.
1996,
Pubmed
,
Xenbase
Lambrecht,
PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.
1992,
Pubmed
McLaren,
Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens.
1994,
Pubmed
North,
Nucleotide receptors.
1997,
Pubmed
Radford,
Baculovirus expression provides direct evidence for heteromeric assembly of P2X2 and P2X3 receptors.
1997,
Pubmed
Rassendren,
Identification of amino acid residues contributing to the pore of a P2X receptor.
1997,
Pubmed
Trezise,
P2 purinoceptor antagonist properties of pyridoxal-5-phosphate.
1994,
Pubmed
Trezise,
The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
1994,
Pubmed
Williams,
P2-Purinoceptors: Advances and therapeutic opportunities.
1995,
Pubmed
Windscheif,
Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.
1994,
Pubmed
Ziganshin,
Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
1994,
Pubmed
Ziganshin,
PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder.
1993,
Pubmed
Ziganshin,
Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown.
1995,
Pubmed
,
Xenbase